1	Insulin-induced	Insulin-induced	B-NP	JJ	B-protein	6	NMOD	17	induced
2	vascular	vascular	I-NP	JJ	I-protein	6	NMOD	0
3	endothelial	endothelial	I-NP	JJ	I-protein	6	NMOD	0
4	growth	growth	I-NP	NN	I-protein	6	NMOD	0
5	factor	factor	I-NP	NN	I-protein	6	NMOD	0
6	expression	expression	I-NP	NN	O	0	ROOT	9	expression
7	in	in	B-PP	IN	O	6	NMOD	0
8	retina	retina	B-NP	NN	O	7	PMOD	0
9	.	.	O	.	O	6	P	0

1	PURPOSE	PURPOSE	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Clinical	Clinical	B-NP	JJ	O	4	NMOD	0
4	studies	study	I-NP	NNS	O	5	SUB	0
5	have	have	B-VP	VBP	O	1	NMOD	0
6	demonstrated	demonstrate	I-VP	VBN	O	5	VC	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	intensive	intensive	B-NP	JJ	O	10	NMOD	0
9	insulin	insulin	I-NP	NN	O	10	NMOD	0
10	therapy	therapy	I-NP	NN	O	11	SUB	19	therapy
11	causes	cause	B-VP	VBZ	O	7	SBAR	0
12	a	a	B-NP	DT	O	14	NMOD	0
13	transient	transient	I-NP	JJ	O	14	NMOD	0
14	worsening	worsening	I-NP	NN	O	11	OBJ	0
15	of	of	B-PP	IN	O	14	NMOD	0
16	retinopathy	retinopathy	B-NP	NN	O	15	PMOD	0
17	.	.	O	.	O	5	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	mechanisms	mechanism	I-NP	NNS	O	15	SUB	0
3	underlying	underlie	B-VP	VBG	O	2	NMOD	0
4	the	the	B-NP	DT	O	7	NMOD	0
5	initial	initial	I-NP	JJ	O	7	NMOD	0
6	insulin-induced	insulin-induced	I-NP	JJ	O	7	NMOD	0
7	deterioration	deterioration	I-NP	NN	O	3	OBJ	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	retinal	retinal	B-NP	JJ	O	10	NMOD	0
10	status	status	I-NP	NN	O	8	PMOD	0
11	in	in	B-PP	IN	O	7	NMOD	0
12	patients	patient	B-NP	NNS	O	11	PMOD	0
13	with	with	B-PP	IN	O	12	NMOD	0
14	diabetes	diabete	B-NP	NNS	O	13	PMOD	0
15	remain	remain	B-VP	VBP	O	0	ROOT	0
16	unknown	unknown	B-ADJP	JJ	O	15	PRD	0
17	.	.	O	.	O	15	P	0

1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	0
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	0
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	8	SUB	0
5	(	(	O	(	O	7	DEP	0
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	0
7	)	)	O	)	O	4	NMOD	0
8	is	be	B-VP	VBZ	O	0	ROOT	0
9	known	know	I-VP	VBN	O	8	VC	0
10	to	to	I-VP	TO	O	11	VMOD	0
11	be	be	I-VP	VB	O	9	VMOD	0
12	operative	operative	B-ADJP	JJ	O	11	PRD	0
13	in	in	B-PP	IN	O	12	AMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	pathogenesis	pathogenesis	I-NP	NN	O	13	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	diabetic	diabetic	B-NP	JJ	O	18	NMOD	0
18	retinopathy	retinopathy	I-NP	NN	O	16	PMOD	0
19	.	.	O	.	O	8	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	current	current	I-NP	JJ	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	0
5	conducted	conduct	I-VP	VBN	O	4	VC	0
6	to	to	I-VP	TO	O	7	VMOD	0
7	characterize	characterize	I-VP	VB	O	5	VMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	effect	effect	I-NP	NN	O	7	OBJ	16	effect
10	of	of	B-PP	IN	O	9	NMOD	0
11	insulin	insulin	B-NP	NN	B-protein	10	PMOD	0
12	on	on	B-PP	IN	O	9	NMOD	0
13	retinal	retinal	B-NP	JJ	B-DNA	16	NMOD	0
14	VEGF	VEGF	I-NP	NN	I-DNA	16	NMOD	0
15	gene	gene	I-NP	NN	I-DNA	16	NMOD	0
16	expression	expression	I-NP	NN	O	12	PMOD	9	expression
17	in	in	B-ADVP	FW	O	16	NMOD	0
18	vitro	vitro	I-ADVP	FW	O	17	AMOD	0
19	and	and	O	CC	O	7	VMOD	0
20	in	in	B-ADVP	FW	O	7	VMOD	0
21	vivo	vivo	I-ADVP	FW	O	20	AMOD	0
22	.	.	O	.	O	4	P	0

1	METHODS	METHODS	B-NP	NNS	O	12	VMOD	0
2	:	:	O	:	O	1	P	0
3	The	The	B-NP	DT	O	4	NMOD	0
4	effect	effect	I-NP	NN	O	12	SUB	16	effect
5	of	of	B-PP	IN	O	4	NMOD	0
6	insulin	insulin	B-NP	NN	B-protein	5	PMOD	0
7	on	on	B-PP	IN	O	4	NMOD	0
8	VEGF	VEGF	B-NP	NN	B-protein	9	NMOD	0
9	expression	expression	I-NP	NN	O	7	PMOD	9	expression
10	in	in	B-ADVP	FW	O	4	NMOD	0
11	vivo	vivo	I-ADVP	FW	O	10	AMOD	0
12	was	be	B-VP	VBD	O	0	ROOT	0
13	examined	examine	I-VP	VBN	O	12	VC	0
14	by	by	B-PP	IN	O	13	VMOD	0
15	in	in	B-NP	FW	O	16	AMOD	0
16	situ	situ	I-NP	FW	O	18	NMOD	0
17	hybridization	hybridization	I-NP	NN	O	18	NMOD	0
18	studies	study	I-NP	NNS	O	14	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	rat	rat	B-NP	NN	B-RNA	23	NMOD	0
21	retinal	retinal	I-NP	JJ	I-RNA	23	NMOD	0
22	VEGF	VEGF	I-NP	NN	I-RNA	23	NMOD	0
23	transcripts	transcript	I-NP	NNS	I-RNA	19	PMOD	0
24	.	.	O	.	O	12	P	0

1	To	To	B-VP	TO	O	2	VMOD	0
2	examine	examine	I-VP	VB	O	29	VMOD	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	mechanisms	mechanism	I-NP	NNS	O	2	OBJ	0
5	by	by	B-PP	IN	O	4	NMOD	0
6	which	which	B-NP	WDT	O	5	PMOD	0
7	insulin	insulin	B-NP	NN	B-protein	8	SUB	0
8	regulates	regulate	B-VP	VBZ	O	5	SBAR	16	regulates
9	VEGF	VEGF	B-NP	NN	B-protein	10	NMOD	0
10	expression	expression	I-NP	NN	O	19	NMOD	9	expression
11	,	,	O	,	O	19	P	0
12	human	human	B-NP	JJ	B-cell_type	19	NMOD	0
13	retinal	retinal	I-NP	JJ	I-cell_type	19	NMOD	0
14	pigment	pigment	I-NP	NN	I-cell_type	19	NMOD	0
15	epithelial	epithelial	B-ADJP	JJ	I-cell_type	19	NMOD	0
16	(	(	O	(	I-cell_type	19	NMOD	0
17	RPE	RPE	B-NP	NN	I-cell_type	19	NMOD	0
18	)	)	I-NP	)	I-cell_type	19	NMOD	0
19	cells	cell	I-NP	NNS	I-cell_type	8	OBJ	0
20	were	be	B-VP	VBD	O	8	VMOD	0
21	exposed	expose	I-VP	VBN	O	20	VC	19	exposed
22	to	to	B-PP	TO	O	21	VMOD	0
23	insulin	insulin	B-NP	NN	B-protein	22	PMOD	0
24	,	,	O	,	O	29	P	0
25	and	and	O	CC	O	29	VMOD	0
26	VEGF	VEGF	B-NP	NN	B-RNA	27	NMOD	0
27	mRNA	mRNA	I-NP	NN	I-RNA	28	NMOD	0
28	levels	level	I-NP	NNS	O	29	SUB	0
29	were	be	B-VP	VBD	O	0	ROOT	0
30	quantified	quantify	I-VP	VBN	O	29	VC	0
31	with	with	B-PP	IN	O	30	VMOD	0
32	RNase	RNase	B-NP	NN	B-protein	34	NMOD	0
33	protection	protection	I-NP	NN	O	34	NMOD	0
34	assays	assay	I-NP	NNS	O	31	PMOD	0
35	(	(	O	(	O	37	DEP	0
36	RPAs	RPA	B-NP	NNS	B-protein	37	DEP	0
37	)	)	O	)	O	34	NMOD	0
38	.	.	O	.	O	29	P	0

1	Conditioned	Condition	B-NP	VBN	O	2	NMOD	0
2	media	medium	I-NP	NNS	O	7	SUB	0
3	from	from	B-PP	IN	O	2	NMOD	0
4	insulin-treated	insulin-treated	B-NP	JJ	B-cell_type	6	NMOD	19	treated
5	RPE	RPE	I-NP	NN	I-cell_type	6	NMOD	0
6	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	0
7	were	be	B-VP	VBD	O	0	ROOT	0
8	assayed	assay	I-VP	VBN	O	7	VC	19	assayed
9	for	for	B-PP	IN	O	8	VMOD	0
10	VEGF	VEGF	B-NP	NN	B-protein	11	NMOD	0
11	protein	protein	I-NP	NN	I-protein	16	NMOD	0
12	and	and	O	CC	O	16	NMOD	0
13	capillary	capillary	B-NP	JJ	O	16	NMOD	0
14	endothelial	endothelial	I-NP	JJ	O	16	NMOD	0
15	cell	cell	I-NP	NN	O	16	NMOD	0
16	proliferation	proliferation	I-NP	NN	O	9	PMOD	1	proliferation
17	.	.	O	.	O	7	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	capacity	capacity	I-NP	NN	O	16	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	insulin	insulin	B-NP	NN	B-protein	3	PMOD	0
5	to	to	B-VP	TO	O	6	VMOD	0
6	stimulate	stimulate	I-VP	VB	O	2	NMOD	17	stimulate
7	the	the	B-NP	DT	O	9	NMOD	0
8	VEGF	VEGF	I-NP	NN	B-DNA	9	NMOD	0
9	promoter	promoter	I-NP	NN	I-DNA	6	OBJ	0
10	linked	link	B-VP	VBN	O	9	NMOD	19	linked
11	to	to	B-PP	TO	O	10	VMOD	0
12	a	a	B-NP	DT	O	15	NMOD	0
13	luciferase	luciferase	I-NP	NN	B-DNA	15	NMOD	0
14	reporter	reporter	I-NP	NN	I-DNA	15	NMOD	0
15	gene	gene	I-NP	NN	I-DNA	11	PMOD	0
16	was	be	B-VP	VBD	O	0	ROOT	0
17	characterized	characterize	I-VP	VBN	O	16	VC	0
18	in	in	B-PP	IN	O	17	VMOD	0
19	transient	transient	B-NP	JJ	O	21	NMOD	0
20	transfection	transfection	I-NP	NN	O	21	NMOD	0
21	assays	assay	I-NP	NNS	O	18	PMOD	0
22	.	.	O	.	O	16	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	18	NMOD	0
2	:	:	O	:	O	1	P	0
3	Insulin	Insulin	B-NP	NN	B-protein	4	SUB	0
4	increased	increase	B-VP	VBD	O	18	NMOD	17	increased
5	VEGF	VEGF	B-NP	NN	B-RNA	7	NMOD	0
6	mRNA	mRNA	I-NP	NN	I-RNA	7	NMOD	0
7	levels	level	I-NP	NNS	O	4	OBJ	0
8	in	in	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	ganglion	ganglion	I-NP	NN	O	8	PMOD	0
11	,	,	O	,	O	18	P	0
12	inner	inner	B-NP	JJ	O	13	NMOD	0
13	nuclear	nuclear	I-NP	JJ	O	18	NMOD	0
14	,	,	O	,	O	18	P	0
15	and	and	O	CC	O	18	NMOD	0
16	RPE	RPE	B-NP	NN	O	18	NMOD	0
17	cell	cell	I-NP	NN	O	18	NMOD	0
18	layers	layer	I-NP	NNS	O	0	ROOT	0
19	.	.	O	.	O	18	P	0

1	In	In	B-ADVP	FW	O	5	VMOD	0
2	vitro	vitro	I-ADVP	FW	O	1	AMOD	0
3	,	,	O	,	O	5	P	0
4	insulin	insulin	B-NP	NN	B-protein	5	SUB	0
5	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
6	VEGF	VEGF	B-NP	NN	B-RNA	8	NMOD	0
7	mRNA	mRNA	I-NP	NN	I-RNA	8	NMOD	0
8	levels	level	I-NP	NNS	O	17	NMOD	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	human	human	B-NP	JJ	B-cell_type	12	NMOD	0
11	RPE	RPE	I-NP	NN	I-cell_type	12	NMOD	0
12	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	0
13	and	and	O	CC	O	17	NMOD	0
14	enhanced	enhance	B-NP	VBN	O	17	NMOD	17	enhanced
15	VEGF	VEGF	I-NP	NN	B-DNA	17	NMOD	0
16	promoter	promoter	I-NP	NN	I-DNA	17	NMOD	0
17	activity	activity	I-NP	NN	O	5	OBJ	0
18	without	without	B-PP	IN	O	5	VMOD	0
19	affecting	affect	B-VP	VBG	O	18	PMOD	0
20	transcript	transcript	B-NP	NN	O	21	NMOD	0
21	stability	stability	I-NP	NN	O	19	OBJ	0
22	.	.	O	.	O	5	P	0

1	Insulin	Insulin	B-NP	NN	B-protein	2	NMOD	0
2	treatment	treatment	I-NP	NN	O	4	SUB	19	treatment
3	also	also	B-ADVP	RB	O	4	VMOD	0
4	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
5	VEGF	VEGF	B-NP	NN	B-protein	7	NMOD	0
6	protein	protein	I-NP	NN	O	7	NMOD	0
7	levels	level	I-NP	NNS	O	4	OBJ	0
8	in	in	B-PP	IN	O	4	VMOD	0
9	conditioned	condition	B-NP	VBN	O	12	NMOD	0
10	RPE	RPE	I-NP	NN	O	12	NMOD	0
11	cell	cell	I-NP	NN	O	12	NMOD	0
12	media	medium	I-NP	NNS	O	8	PMOD	0
13	in	in	B-PP	IN	O	12	NMOD	0
14	a	a	B-NP	DT	O	16	NMOD	0
15	dose-dependent	dose-dependent	I-NP	JJ	O	16	NMOD	0
16	manner	manner	I-NP	NN	O	13	PMOD	0
17	with	with	B-PP	IN	O	4	VMOD	0
18	a	a	B-NP	DT	O	21	NMOD	0
19	median	median	I-NP	JJ	O	21	NMOD	0
20	effective	effective	I-NP	JJ	O	21	NMOD	0
21	concentration	concentration	I-NP	NN	O	17	PMOD	0
22	of	of	B-PP	IN	O	21	NMOD	0
23	5	5	B-NP	CD	O	24	NMOD	0
24	nM	nM	I-NP	NN	O	22	PMOD	0
25	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	5	NMOD	0
2	insulin-conditioned	insulin-conditioned	I-NP	JJ	O	5	NMOD	0
3	RPE	RPE	I-NP	NN	O	5	NMOD	0
4	cell	cell	I-NP	NN	O	5	NMOD	0
5	media	medium	I-NP	NNS	O	6	SUB	0
6	stimulated	stimulate	B-VP	VBD	O	0	ROOT	17	stimulated
7	capillary	capillary	B-NP	JJ	O	10	NMOD	0
8	endothelial	endothelial	I-NP	JJ	O	10	NMOD	0
9	cell	cell	I-NP	NN	O	10	NMOD	0
10	proliferation	proliferation	I-NP	NN	O	13	NMOD	1	proliferation
11	,	,	O	,	O	13	P	0
12	an	an	B-NP	DT	O	13	NMOD	0
13	effect	effect	I-NP	NN	O	6	OBJ	0
14	that	that	B-NP	WDT	O	13	NMOD	0
15	was	be	B-VP	VBD	O	14	SBAR	0
16	completely	completely	I-VP	RB	O	15	VMOD	0
17	blocked	block	I-VP	VBN	O	15	VC	18	blocked
18	by	by	B-PP	IN	O	17	VMOD	0
19	anti-VEGF	anti-VEGF	B-NP	JJ	B-protein	21	NMOD	0
20	neutralizing	neutralize	I-NP	VBG	I-protein	21	NMOD	0
21	antibody	antibody	I-NP	NN	I-protein	18	PMOD	0
22	.	.	O	.	O	6	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Insulin	Insulin	B-NP	NN	B-protein	4	SUB	0
4	increases	increase	B-VP	VBZ	O	1	NMOD	17	increases
5	VEGF	VEGF	B-NP	NN	B-RNA	6	NMOD	0
6	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD	0
7	and	and	O	CC	O	10	NMOD	0
8	secreted	secrete	B-NP	VBN	O	10	NMOD	0
9	protein	protein	I-NP	NN	O	10	NMOD	0
10	levels	level	I-NP	NNS	O	4	OBJ	0
11	in	in	B-PP	IN	O	10	NMOD	0
12	RPE	RPE	B-NP	NN	B-cell_line	13	NMOD	0
13	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	0
14	through	through	B-PP	IN	O	4	VMOD	0
15	enhanced	enhance	B-NP	VBN	O	16	NMOD	17	enhanced
16	transcription	transcription	I-NP	NN	O	14	PMOD	10	transcription
17	of	of	B-PP	IN	O	16	NMOD	0
18	the	the	B-NP	DT	O	20	NMOD	0
19	VEGF	VEGF	I-NP	NN	B-DNA	20	NMOD	0
20	gene	gene	I-NP	NN	I-DNA	17	PMOD	0
21	.	.	O	.	O	1	P	0

1	Intensive	Intensive	B-NP	JJ	O	3	NMOD	0
2	insulin	insulin	I-NP	NN	O	3	NMOD	0
3	therapy	therapy	I-NP	NN	O	4	SUB	19	therapy
4	may	may	B-VP	MD	O	0	ROOT	0
5	cause	cause	I-VP	VB	O	4	VC	0
6	a	a	B-NP	DT	O	8	NMOD	0
7	transient	transient	I-NP	JJ	O	8	NMOD	0
8	worsening	worsening	I-NP	NN	O	5	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	retinopathy	retinopathy	B-NP	NN	O	9	PMOD	0
11	in	in	B-PP	IN	O	5	VMOD	0
12	patients	patient	B-NP	NNS	O	11	PMOD	0
13	with	with	B-PP	IN	O	12	NMOD	0
14	diabetes	diabetes	B-NP	NN	O	13	PMOD	0
15	through	through	B-PP	IN	O	5	VMOD	0
16	increased	increase	B-NP	VBN	O	20	NMOD	17	increased
17	retinal	retinal	I-NP	JJ	O	20	NMOD	0
18	VEGF	VEGF	I-NP	NN	O	20	NMOD	0
19	gene	gene	I-NP	NN	O	20	NMOD	0
20	expression	expression	I-NP	NN	O	15	PMOD	9	expression
21	.	.	O	.	O	4	P	0

